Analyst Downgrades – Spark Therapeutics (NASDAQ:ONCE) Stock Gets Downgraded By JPMorgan Chase & Co. from Overweight to Neutral

Analyst Ratings For Spark Therapeutics (NASDAQ:ONCE)

Today, Spark Therapeutics (NASDAQ:ONCE) stock was downgraded by JPMorgan Chase & Co. from Overweight to Neutral.

Some recent analyst ratings include

  • 2/14/2018-JPMorgan Chase & Co. was Downgraded by analysts at JPMorgan Chase & Co. from a “Overweight ” rating to a ” Neutral” rating.
  • 2/12/2018-Mizuho initiated coverage with a Buy rating.
  • 2/8/2018-Royal Bank of Canada Reiterated Rating of Outperform .
  • 1/25/2018-Wedbush Reiterated Rating of Underperform .
  • 1/24/2018-Cantor Fitzgerald Reiterated Rating of Buy.
  • 1/23/2018-Barclays Reiterated Rating of Overweight .

Recent Insider Trading Activity For Spark Therapeutics (NASDAQ:ONCE)
Spark Therapeutics (NASDAQ:ONCE) has insider ownership of 7.30% and institutional ownership of 95.87%.

  • On 12/11/2017 John Furey, COO, sold 18 with an average share price of $46.33 per share and the total transaction amounting to $833.94.
  • On 12/8/2017 John Furey, COO, bought 18 with an average share price of $73.48 per share and the total transaction amounting to $1,322.64.
  • On 11/28/2017 Katherine A High, Insider, sold 5,000 with an average share price of $71.32 per share and the total transaction amounting to $356,600.00.
  • On 11/16/2017 Stephen W Webster, CFO, sold 10,000 with an average share price of $70.14 per share and the total transaction amounting to $701,400.00.
  • On 11/13/2017 Barge Joseph La, Insider, sold 5,500 with an average share price of $71.44 per share and the total transaction amounting to $392,920.00.
  • On 11/13/2017 Jeffrey D Marrazzo, CEO, sold 20,000 with an average share price of $71.54 per share and the total transaction amounting to $1,430,800.00.
  • On 11/9/2017 Barge Joseph La, Insider, sold 3,309 with an average share price of $71.31 per share and the total transaction amounting to $235,964.79.

Recent Trading Activity for Spark Therapeutics (NASDAQ:ONCE)
Shares of Spark Therapeutics closed the previous trading session at 53.90 down -0.90 1.64% with 54.349998474121094 shares trading hands.

An ad to help with our costs